Global Long-Acting Drug Delivery Technologies and Services Market 2023-2033: Navigating Regulatory Complexities, Key to Success
December 22, 2023 10:08 ET
|
Research and Markets
Dublin, Dec. 22, 2023 (GLOBE NEWSWIRE) -- The "Long-Acting Drug Delivery Technologies and Services Market: A Global and Regional Analysis, 2023-2033" report has been added to ...
United States Connected Drug Delivery Devices Market Report 2023-2028: Increasing R&D Activities and Rise in Prevalence of Chronic Diseases Bolster Growth
December 13, 2023 03:48 ET
|
Research and Markets
Dublin, Dec. 13, 2023 (GLOBE NEWSWIRE) -- The "United States Connected Drug Delivery Devices Market by Product Type, Technology, Application, End-user, Region, Competition Forecast &...
Nanomedicine Market Valuation to Reach USD 358 Billion by 2032 | Amid Rising Demand for Advanced Medical Solutions and Precision Healthcare
December 12, 2023 10:06 ET
|
Market.Us
New York, Dec. 12, 2023 (GLOBE NEWSWIRE) -- According to the market.us, the global nanomedicine market reached a value of USD 153 billion in 2023 and is projected to witness substantial growth,...
Global Drug Eluting Stent Research Report 2023: A $13.65 Billion Market by 2030 - Technological Advancements in Stent Design and Rising Geriatric Populations Fueling Growth
December 12, 2023 03:23 ET
|
Research and Markets
Dublin, Dec. 12, 2023 (GLOBE NEWSWIRE) -- The "Drug Eluting Stent Market Size, Share & Trends Analysis Report By Coating Type (Polymer-based Coatings (Non-biodegradable, Biodegradable)),...
Gold Nanoparticles Market Size to Surpass USD 11.8 Billion by 2031, at 10.6% CAGR – Report by Transparency Market Research Inc.
December 08, 2023 12:30 ET
|
Transparency Market Research
Wilmington, Delaware, United States, Dec. 08, 2023 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - The global gold nanoparticles market is estimated to flourish at a CAGR of 10.6% from 2023...
Ractigen Therapeutics Advances into Clinical Stage with Groundbreaking saRNA Drug, RAG-01
December 06, 2023 07:00 ET
|
Ractigen Therapeutics
This milestone marks Ractigen's transition into clinical development, with RAG-01 targeting NMIBC.
EsoCap reports positive topline results from ACESO Phase II trial investigating ESO-101 in eosinophilic esophagitis
December 05, 2023 03:00 ET
|
EsoCap AG
ESO-101, EsoCap's lead product candidate, consists of a capsule with a rolled-up, thin mucoadhesive film with the anti-inflammatory corticosteroid, mometasone furoateEsoCap's novel targeted delivery...
Vaccines Market to Hit USD 99.3 billion by 2031, at a CAGR 4.2% | Says Transparency Market Research, Inc.
December 01, 2023 07:30 ET
|
Transparency Market Research
Wilmington, Delaware, United States, Dec. 01, 2023 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - The global vaccines market was estimated at a value of US$ 119.1 billion in 2022. It is...
Global Gastroretentive Drug Delivery Systems Outsourcing Market Report 2023-2030 - Market Thrives Amid Growing Demand for Targeted GI Treatments
November 28, 2023 09:08 ET
|
Research and Markets
Dublin, Nov. 28, 2023 (GLOBE NEWSWIRE) -- The "Gastroretentive Drug Delivery Systems Outsourcing Market Size, Share & Trends Analysis Report By Dosage Form (Tablets, Liquid, Microspheres,...
Artificial Intelligence in Drug Discovery Market to Hit US$ 3,547.4 Million by 2030: Coherent Market Insights
November 24, 2023 06:30 ET
|
CMI
Burlingame, Nov. 24, 2023 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, The global artificial intelligence in drug discovery market was valued at US$ 1,016.1Mn in 2022 and is forecast...